AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18502781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 15899749 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention for YPLH
Number of subjects: 0
Study 12623815 — intervention group
Group type: EXPERIMENTAL
Intervention: PRK for myopia and astigmatism
Number of subjects: 19
Study 10582840 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD combined type (DSM-IV)
Number of subjects: 0
Study 8694682 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine for 9 months combined with 15 weekly sessions of brief dynamic psychotherapy
Number of subjects: 40
Study 8694682 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine for 9 months
Number of subjects: 40
Study 1931397 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine triphosphate (ATP) 0.05 mg kg‐1 or 0.1 mg kg‐1
Number of subjects: 20
Study 1931397 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 20
Study 6285947 — intervention group
Group type: EXPERIMENTAL
Intervention: Large fractions of radiation with high-dose metronidazole
Number of subjects: 66
Study 6285947 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation as in Group 2 but with equitoxic doses of MISO
Number of subjects: 66
Study 6285947 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiation alone
Number of subjects: 66
Study 31687775 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted navigation
Number of subjects: 3
Study 28154331 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedra Herb extract (EFE)
Number of subjects: 12
Study 28154331 — intervention group
Group type: COMPARATOR
Intervention: Ephedra Herb
Number of subjects: 12
Study 28154331 — intervention group
Group type: EXPERIMENTAL
Intervention: EFE (different amounts)
Number of subjects: 12
Study 26025218 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization (percutaneous coronary intervention or coronary artery bypass graft) performed during index hospitalization in 8,586 patients (68.0%)
Number of subjects: 12635
Study 26025218 — intervention group
Group type: COMPARATOR
Intervention: No revascularization
Number of subjects: 12635
Study 25055754 — intervention group
Group type: EXPERIMENTAL
Intervention: Unipolar hemiarthroplasty
Number of subjects: 175
Study 25055754 — intervention group
Group type: COMPARATOR
Intervention: Bipolar hemiarthroplasty
Number of subjects: 175
Study 22249844 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTA (24%)
Number of subjects: 40
Study 22249844 — intervention group
Group type: EXPERIMENTAL
Intervention: PDGF (25 ng/ml)
Number of subjects: 40
Study 22249844 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined application of EDTA and PDGF
Number of subjects: 40
Study 22249844 — intervention group
Group type: COMPARATOR
Intervention: SRP (scaling root planing)
Number of subjects: 40
Study 22249844 — intervention group
Group type: COMPARATOR
Intervention: Diseased (untreated)
Number of subjects: 40
Study 20218746 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiparasitic and anti-infective drugs
Number of subjects: 158
Study 17548704 — intervention group
Group type: EXPERIMENTAL
Intervention: Total dietary iron intake
Number of subjects: 49654
Study 17548704 — intervention group
Group type: EXPERIMENTAL
Intervention: Heme iron intake
Number of subjects: 49654
Study 17548704 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron intake in women consuming 30+ g of alcohol per day
Number of subjects: 49654
Study 17548704 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron intake in women who had ever used hormone replacement therapy
Number of subjects: 49654
Study 15823510 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (1000-4000 mg/day)
Number of subjects: 0
Study 15823510 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11953637 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary rod
Number of subjects: 18
Study 11953637 — intervention group
Group type: COMPARATOR
Intervention: Two insertion techniques
Number of subjects: 18
Study 9798656 — intervention group
Group type: EXPERIMENTAL
Intervention: Folate supplementation after one week of vitamins B6 and B12 supplementation.
Number of subjects: 46
Study 9798656 — intervention group
Group type: COMPARATOR
Intervention: Normal hemoglobin (HbAA) controls.
Number of subjects: 46
Study 9798656 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B6 and B12 supplementation.
Number of subjects: 46
Study 9638199 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous oximetry measurements before and three weeks after surgery
Number of subjects: 172
Study 9638199 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous oximetry measurements
Number of subjects: 172
Study 2095023 — intervention group
Group type: COMPARATOR
Intervention: Mersilene interrupted sutures
Number of subjects: 68
Study 2095023 — intervention group
Group type: EXPERIMENTAL
Intervention: Single adjustable running Mersilene suture
Number of subjects: 68
Study 705848 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 200 mg doxycycline
Number of subjects: 149
Study 705848 — intervention group
Group type: COMPARATOR
Intervention: Seven day course of tetracycline
Number of subjects: 149
Study 31733275 — intervention group
Group type: EXPERIMENTAL
Intervention: Total serum PSA
Number of subjects: 603
Study 31733275 — intervention group
Group type: EXPERIMENTAL
Intervention: Free-PSA ratio
Number of subjects: 603
Study 31733275 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA density
Number of subjects: 603
Study 30643398 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol fumarate inhalation solution (FFIS; 20 µg, n=541)
Number of subjects: 1071
Study 30643398 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=530)
Number of subjects: 1071
Study 30643398 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol fumarate inhalation solution (FFIS)
Number of subjects: 1071
Study 30643398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1071
Study 25779636 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed suction (CS) system
Number of subjects: 13
Study 25779636 — intervention group
Group type: COMPARATOR
Intervention: Open suction (OS) system
Number of subjects: 13
Study 26077038 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise
Number of subjects: 14
Study 26077038 — intervention group
Group type: COMPARATOR
Intervention: Albuterol
Number of subjects: 14
Study 23442752 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ml mepivacaine 1%
Number of subjects: 10
Study 21481449 — intervention group
Group type: EXPERIMENTAL
Intervention: Phentermine 7.5 mg plus topiramate 46.0 mg
Number of subjects: 2487
Study 21481449 — intervention group
Group type: EXPERIMENTAL
Intervention: Phentermine 15.0 mg plus topiramate 92.0 mg
Number of subjects: 2487
Study 21481449 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2487
Study 19228842 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/d
Number of subjects: 4731
Study 16374021 — intervention group
Group type: EXPERIMENTAL
Intervention: omalizumab
Number of subjects: 34
Study 16374021 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 34
Study 14652086 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine+Nap (200 mg caffeine followed by a 20 min nap)
Number of subjects: 10
Study 14652086 — intervention group
Group type: EXPERIMENTAL
Intervention: Nap+Bright-light (2000 lx of bright light for 1 min after a 20 min nap)
Number of subjects: 10
Study 14652086 — intervention group
Group type: EXPERIMENTAL
Intervention: Nap+Face-washing (washing faces immediately after a 20 min nap)
Number of subjects: 10
Study 14652086 — intervention group
Group type: COMPARATOR
Intervention: Nap only (20 min nap)
Number of subjects: 10
Study 14652086 — intervention group
Group type: COMPARATOR
Intervention: No-Nap (rest without sleep)
Number of subjects: 10
Study 11061612 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine administered intravenously at 1250 mg/m2 over 30-60 minutes on days 1, 8, and 15 followed by 1 week of rest, maximum of six cycles
Number of subjects: 21
Study 8550052 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa (IFN-alpha) treatment
Number of subjects: 35
Study 8550052 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 35
Study 1405579 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast (B)
Number of subjects: 35
Study 1405579 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 35
Study 2865188 — intervention group
Group type: EXPERIMENTAL
Intervention: SRM plus TTS‐TNG
Number of subjects: 10
Study 2865188 — intervention group
Group type: COMPARATOR
Intervention: SRM alone
Number of subjects: 10
Study 2865188 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 29426869 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP) - 2 placebo pills twice a day for 21 days
Number of subjects: 74
Study 29426869 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 74
Study 27676665 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine plus bupivacaine in Pecs block
Number of subjects: 60
Study 27676665 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine alone in Pecs block
Number of subjects: 60
Study 24883390 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS
Number of subjects: 5
Study 24883390 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS
Number of subjects: 5
Study 24883390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 23409612 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatic acupuncture
Number of subjects: 35
Study 23409612 — intervention group
Group type: COMPARATOR
Intervention: Ear acupuncture
Number of subjects: 35
Study 19969355 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Mentor program (digital video disc)
Number of subjects: 68
Study 19969355 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching materials (control group)
Number of subjects: 68
Study 18457463 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosapride
Number of subjects: 1042
Study 15915022 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 degrees head-up position
Number of subjects: 42
Study 15915022 — intervention group
Group type: COMPARATOR
Intervention: supine position
Number of subjects: 42
Study 15316804 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator based desensitisation exposure (Group S)
Number of subjects: 40
Study 15316804 — intervention group
Group type: COMPARATOR
Intervention: Customised exercise regime (Group C)
Number of subjects: 40
Study 15316804 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Group C and Group S)
Number of subjects: 40
Study 11556409 — intervention group
Group type: EXPERIMENTAL
Intervention: 75+HA conducted in the participant's home by a nurse
Number of subjects: 100
Study 11556409 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 100
Study 9431710 — intervention group
Group type: EXPERIMENTAL
Intervention: Cow udder ointment
Number of subjects: 30
Study 9431710 — intervention group
Group type: COMPARATOR
Intervention: Petrolatum (placebo)
Number of subjects: 30
Study 8500321 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal arcus presence
Number of subjects: 447
Study 8500321 — intervention group
Group type: EXPERIMENTAL
Intervention: Old age and high LDL cholesterol concentration
Number of subjects: 447
Study 8500321 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographically assessed atherosclerosis
Number of subjects: 447
Study 3511410 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 42
Study 3511410 — intervention group
Group type: COMPARATOR
Intervention: Pentazocin
Number of subjects: 42
Study 29289490 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP-5 (5 cm H2O)
Number of subjects: 51
Study 29289490 — intervention group
Group type: COMPARATOR
Intervention: PEEP-0 (no PEEP)
Number of subjects: 51
Study 29289490 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PEEP-0 and PEEP-5
Number of subjects: 51
Study 27668723 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior psychophysiological therapy (CBPT)
Number of subjects: 53
Study 27668723 — intervention group
Group type: COMPARATOR
Intervention: Music and relaxation therapy (MRT)
Number of subjects: 53
Study 25463149 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvement plans focusing on CVRM in intervention group (n=22)
Number of subjects: 45
Study 25463149 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=23) focusing on any domain except CVRM and diabetes mellitus
Number of subjects: 45
Study 22891826 — intervention group
Group type: EXPERIMENTAL
Intervention: Orbital Atherectomy + Balloon Angioplasty
Number of subjects: 50
Study 22891826 — intervention group
Group type: COMPARATOR
Intervention: Balloon Angioplasty alone
Number of subjects: 50
Study 22891826 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual stenosis >30%
Number of subjects: 50
Study 19703826 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency chest wall oscillation (HFCWO)
Number of subjects: 29
Study 19703826 — intervention group
Group type: COMPARATOR
Intervention: Usual airway clearance techniques (ACTs)
Number of subjects: 29
Study 18940714 — intervention group
Group type: EXPERIMENTAL
Intervention: Peppermint and neroli hydrolat spray
Number of subjects: 44
Study 18940714 — intervention group
Group type: COMPARATOR
Intervention: Plain water spray
Number of subjects: 44
Study 18940714 — intervention group
Group type: EXPERIMENTAL
Intervention: Both sprays
Number of subjects: 44
Study 16647152 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-mastectomy radiotherapy (RT)
Number of subjects: 3083
Study 16647152 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with surgery and RT at the time of LRR
Number of subjects: 3083
Study 16647152 — intervention group
Group type: COMPARATOR
Intervention: Surgery or RT alone
Number of subjects: 3083
Study 16647152 — intervention group
Group type: COMPARATOR
Intervention: Initial randomization group
Number of subjects: 3083
Study 12839215 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminoguanidine
Number of subjects: 0
Study 12839215 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridoxyliden‐aminoguanidine
Number of subjects: 0
Study 12839215 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridoxal
Number of subjects: 0
Study 12839215 — intervention group
Group type: COMPARATOR
Intervention: Pyridoxyliden‐aminoguanidine (PAG)
Number of subjects: 0
Study 11005605 — intervention group
Group type: EXPERIMENTAL
Intervention: NIRS monitoring during CPB
Number of subjects: 41
Study 11005605 — intervention group
Group type: EXPERIMENTAL
Intervention: NIRS monitoring in the oxygenation study
Number of subjects: 41
Study 11005605 — intervention group
Group type: COMPARATOR
Intervention: NIRS monitoring during DHCA
Number of subjects: 41
Study 11005605 — intervention group
Group type: EXPERIMENTAL
Intervention: NIRS monitoring during validation study
Number of subjects: 41
Study 14688947 — intervention group
Group type: COMPARATOR
Intervention: Single phototherapy (N=43)
Number of subjects: 80
Study 14688947 — intervention group
Group type: EXPERIMENTAL
Intervention: Double phototherapy (N=37)
Number of subjects: 80
Study 14688947 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Single and Double phototherapy)
Number of subjects: 80
Study 1728203 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine (0.38 mg/kg body weight)
Number of subjects: 40
Study 1728203 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine (0.84 mg/kg body weight)
Number of subjects: 40
Study 1728203 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole (0.84 mg/kg body weight)
Number of subjects: 40
Study 1728203 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 40
Study 3968295 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol at 2 micrograms . min‐1
Number of subjects: 12
Study 3968295 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol at 4 micrograms . min‐1
Number of subjects: 12
Study 3968295 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine at 200 micrograms . min‐1
Number of subjects: 12
Study 3968295 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine at 400 micrograms . min‐1
Number of subjects: 12
Study 3968295 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine at 250 micrograms . min‐1
Number of subjects: 12
Study 3968295 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine at 500 micrograms . min‐1
Number of subjects: 12
Study 31499528 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE) (0.625 mg/d)
Number of subjects: 9939
Study 31499528 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9939
Study 30039171 — intervention group
Group type: EXPERIMENTAL
Intervention: Sudden wean from nCPAP
Number of subjects: 372
Study 30039171 — intervention group
Group type: COMPARATOR
Intervention: Pressure wean from nCPAP
Number of subjects: 372
Study 27091036 — intervention group
Group type: EXPERIMENTAL
Intervention: Helicobacter pylori standard treatment for two weeks followed by antacid medication (morning and night) for three months
Number of subjects: 120
Study 27091036 — intervention group
Group type: COMPARATOR
Intervention: Antacid medication (morning and night) for four weeks followed by three months of antacid treatment
Number of subjects: 120
Study 25374219 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycemia group (fasting glucose≥126 mg/dl and/or random blood glucose≥200 mg/dl)
Number of subjects: 159
Study 25374219 — intervention group
Group type: COMPARATOR
Intervention: Euglycemia group (normal blood glucose values)
Number of subjects: 159
Study 25374219 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycemia group
Number of subjects: 159
Study 25374219 — intervention group
Group type: COMPARATOR
Intervention: Euglycemia group
Number of subjects: 159
Study 23364032 — intervention group
Group type: EXPERIMENTAL
Intervention: Case-based small group learning program, once a week for 5 weeks
Number of subjects: 69
Study 23364032 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 69
Study 20443023 — intervention group
Group type: EXPERIMENTAL
Intervention: High stretch loads during lateral jumps
Number of subjects: 9
Study 17653959 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT) with 2 mg 17beta-estradiol/10 mg dydrogesterone (Femoston) for seven 28-day cycles
Number of subjects: 40
Study 17653959 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 40
Study 17653959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 16563251 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/day)
Number of subjects: 40
Study 16563251 — intervention group
Group type: COMPARATOR
Intervention: Routine therapy
Number of subjects: 40
Study 16563251 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib (10 micromol/L)
Number of subjects: 40
Study 11867945 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 30
Study 11867945 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 30
Study 11867945 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 30
Study 10087460 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) therapy
Number of subjects: 0
Study 10087460 — intervention group
Group type: COMPARATOR
Intervention: Theophylline (Respicur retard(R) 400 mg) therapy
Number of subjects: 0
Study 7754404 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous cryotherapy (Polar Care Model 500)
Number of subjects: 40
Study 7754404 — intervention group
Group type: COMPARATOR
Intervention: Intermittent cryotherapy (standard therapy with cool packs)
Number of subjects: 40
Study 2181915 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin + clavulanic acid (40 mg/kg/day in 3 or 4 divided doses)
Number of subjects: 111
Study 2181915 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin-sulfisoxazole (Pediazole, 50 mg/kg/day in 3 divided doses)
Number of subjects: 111
Study 534604 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone valerate aerosol (800 microgram/day)
Number of subjects: 81
Study 534604 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 81
Study 534604 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (betamethasone and control)
Number of subjects: 81
Study 534604 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral candidiasis
Number of subjects: 81
Study 30125346 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV-mRNA (Aptima, Hologic)
Number of subjects: 1204
Study 30125346 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV-DNA (Cobas 4800, Roche)
Number of subjects: 1204
Study 27762489 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg thrice daily oral tranexamic acid plus HQ 4% cream nightly
Number of subjects: 100
Study 27762489 — intervention group
Group type: COMPARATOR
Intervention: HQ 4% cream only
Number of subjects: 100
Study 25968575 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE) after 8 weeks of chronic RT
Number of subjects: 14
Study 25968575 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute RE
Number of subjects: 14
Study 25968575 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 weeks of RT
Number of subjects: 14
Study 24199872 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical feeding evaluation with cervical auscultation (CFE + CA)
Number of subjects: 216
Study 24199872 — intervention group
Group type: COMPARATOR
Intervention: Clinical feeding evaluation only (CFE)
Number of subjects: 216
Study 21388750 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% betaine
Number of subjects: 20
Study 21388750 — intervention group
Group type: COMPARATOR
Intervention: 1% CLA
Number of subjects: 20
Study 21388750 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% betaine + 1% CLA
Number of subjects: 20
Study 21388750 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study 19965324 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of furosemide (Group 2, n=50, 10mg/ml)
Number of subjects: 100